XML 44 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (50,513,568) $ (33,535,748)
Adjustment to reconcile to net loss to net cash used in operating activities:    
Depreciation expense 247,199 45,467
Right-of-use asset amortization 519,541 113,605
Amortization of intangibles 30,053  
Stock based compensation expense 4,064,446 1,802,623
Net amortization of premium (accretion of discount) on marketable securities (171,382) 130,240
Loss on disposal of fixed assets 5,170  
Deferred tax benefit   (307,485)
(Increase) decrease in:    
Accounts receivable 233,623 279,713
Prepaid expenses and other current assets (284,346) (2,408,986)
Other assets (360,200)  
Increase (decrease) in:    
Accounts payable 1,760,217 (130,398)
Accrued expenses 474,568 3,240,940
Lease liability (126,382) (80,853)
Other liabilities 19,796  
Net provided by cash (used in) operating activities (44,101,265) (30,850,882)
Cash flows from investing activities:    
Purchases of property and equipment (742,483) (60,786)
Purchases of marketable securities (50,104,515) (75,625,529)
Maturities of marketable securities 92,678,000  
Cash acquired in business combination   70,348
Net cash used in investing activities 41,831,002 (75,615,967)
Cash flows from financing activities:    
Proceeds from initial public offering of common stock, net of commissions and underwriting   120,318,750
Payment of initial public offering costs   (2,124,317)
Payment of public offering costs (281,375)  
Proceeds from exercise of stock options 300,379 354,434
Proceeds from exercise of warrants   927,125
Net cash provided by financing activities 19,004 144,264,843
Net increase (decrease) in cash and cash equivalents (2,251,259) 37,797,994
Cash and cash equivalents at beginning of period 74,888,145 37,090,151
Cash and cash equivalents at end of period 72,636,886 74,888,145
Supplemental disclosures of noncash investing and financing information:    
Conversion of convertible Series A and B preferred stock into common stock   82,892,701
Business combination non cash   $ 7,804,652
Class A common stock issued for business combination   7,875,000
Reduction of right of use asset and lease liability in connection with lease modification 396,901  
Property and equipment in accounts payable/accrued expenses $ 72,272  
Series B Preferred Stock    
Cash flows from financing activities:    
Proceeds from the issuance of preferred stock, net of issuance costs   $ 24,788,851